FdaApplication
NDA 213426
Identifiers
- fda_app_no: NDA213426
Properties
| Property | Value |
|---|---|
| applicant_name | KOWA PHARMACEUTICALS AMERICA INC |
| application_type | NDA |
| approval_date | 2021-10-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SEGLENTIS | CELECOXIB; TRAMADOL HYDROCHLORIDE | 56MG;44MG | TABLET;ORAL |
1 product